Risk factors for placenta accreta
Objective: To identify risk factors associated with placenta accreta in a large cohort study. Methods: Data for this study came from the Taiwan Down Syndrome Screening Group, an ongoing project on feasibility of serum screening in an Asian population. Women who had serum screening for Down syndrome...
Gespeichert in:
| Veröffentlicht in: | Obstetrics and gynecology (New York. 1953) 1999-04, Vol.93 (4), p.545-550 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 550 |
|---|---|
| container_issue | 4 |
| container_start_page | 545 |
| container_title | Obstetrics and gynecology (New York. 1953) |
| container_volume | 93 |
| creator | Hung, Tai-Ho Shau, Wen-Yi Hsieh, Ching-Chang Chiu, Tsung-Hong Hsu, Jenn-Jeih Hsieh, T’Sang-T’Ang |
| description | Objective: To identify risk factors associated with placenta accreta in a large cohort study.
Methods: Data for this study came from the Taiwan Down Syndrome Screening Group, an ongoing project on feasibility of serum screening in an Asian population. Women who had serum screening for Down syndrome at 14–22 weeks’ gestation using alpha-fetoprotein (AFP) and free β-hCG between January 1994 and June 1997, and delivered in the same institution, were included (
n = 10,672). Those who had multiple gestations (
n = 200), overt diabetes (
n = 11), or fetal malformations (
n = 101) were excluded. If a woman was involved more than once, one randomly selected pregnancy was included in the analysis (
n = 9349). Twenty-eight pregnancies were complicated by placenta accreta, diagnosed by clinical presentation (
n = 26) or histologic confirmation (
n = 2). Multiple logistic regression with adjustment for potentially confounding variables was used to identify independent risk factors for placenta accreta.
Results: Women who had placenta previa (odds ratio [OR] 54.2; 95% confidence interval [CI] 17.8, 165.5) and second-trimester serum levels of AFP and free β-hCG greater than 2.5 multiples of the median (OR 8.3; 95% CI 1.8, 39.3 and OR 3.9; 95% CI 1.5, 9.9, respectively), and were 35 years and older (OR 3.2; 95% CI 1.1, 9.4) were at increased risk of having placenta accreta.
Conclusion: Risk factors for placenta accreta include placenta previa, abnormally elevated second-trimester AFP and free β-hCG levels, and advanced maternal age. |
| doi_str_mv | 10.1016/S0029-7844(98)00460-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69711062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0029784498004608</els_id><sourcerecordid>69711062</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4195-161908b7b5a3fe24ae4d97f54b713efa515f9925423f2a0bdd16b0fd62320ef33</originalsourceid><addsrcrecordid>eNqFkFtr2zAUgMXYWNNsP2Ejg1K6B2_n6GJbT6WEXgaBwS6wNyHLR8SrY6eS09B_PzkO6972JATfp6PzMfYO4RMC5p-_A3CdFaWUF7r8CCBzyMoXbIZlITIuxK-XbPYXOWGnMf4GSKIWr9kJAkdZCpyxD9-aeL_w1g19iAvfh8W2tY66wS6sc4EG-4a98raN9PZ4ztnPm-sfy7ts9fX2y_JqlTmJWmWYo4ayKiplhScuLclaF17JqkBB3ipUXmuuJBeeW6jqGvMKfJ1zwYG8EHN2Pr27Df3DjuJgNk101La2o34XTa4LREj4nKkJdKGPMZA329BsbHgyCGZsYw5tzLi40aU5tDFl8t4fB-yqDdX_WFOMBJwdARudbX2wnWviM1cIEEolTE7Yvm8HCvG-3e0pmDXZdlinaZA-qSBDrTXIdMvG7qN2OWmUIj42yYiuoc5R3QRyg6n75j8L_AElCY2U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69711062</pqid></control><display><type>article</type><title>Risk factors for placenta accreta</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Hung, Tai-Ho ; Shau, Wen-Yi ; Hsieh, Ching-Chang ; Chiu, Tsung-Hong ; Hsu, Jenn-Jeih ; Hsieh, T’Sang-T’Ang</creator><creatorcontrib>Hung, Tai-Ho ; Shau, Wen-Yi ; Hsieh, Ching-Chang ; Chiu, Tsung-Hong ; Hsu, Jenn-Jeih ; Hsieh, T’Sang-T’Ang</creatorcontrib><description>Objective: To identify risk factors associated with placenta accreta in a large cohort study.
Methods: Data for this study came from the Taiwan Down Syndrome Screening Group, an ongoing project on feasibility of serum screening in an Asian population. Women who had serum screening for Down syndrome at 14–22 weeks’ gestation using alpha-fetoprotein (AFP) and free β-hCG between January 1994 and June 1997, and delivered in the same institution, were included (
n = 10,672). Those who had multiple gestations (
n = 200), overt diabetes (
n = 11), or fetal malformations (
n = 101) were excluded. If a woman was involved more than once, one randomly selected pregnancy was included in the analysis (
n = 9349). Twenty-eight pregnancies were complicated by placenta accreta, diagnosed by clinical presentation (
n = 26) or histologic confirmation (
n = 2). Multiple logistic regression with adjustment for potentially confounding variables was used to identify independent risk factors for placenta accreta.
Results: Women who had placenta previa (odds ratio [OR] 54.2; 95% confidence interval [CI] 17.8, 165.5) and second-trimester serum levels of AFP and free β-hCG greater than 2.5 multiples of the median (OR 8.3; 95% CI 1.8, 39.3 and OR 3.9; 95% CI 1.5, 9.9, respectively), and were 35 years and older (OR 3.2; 95% CI 1.1, 9.4) were at increased risk of having placenta accreta.
Conclusion: Risk factors for placenta accreta include placenta previa, abnormally elevated second-trimester AFP and free β-hCG levels, and advanced maternal age.</description><identifier>ISSN: 0029-7844</identifier><identifier>EISSN: 1873-233X</identifier><identifier>DOI: 10.1016/S0029-7844(98)00460-8</identifier><identifier>PMID: 10214831</identifier><identifier>CODEN: OBGNAS</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; alpha-Fetoproteins - analysis ; Biological and medical sciences ; Chorionic Gonadotropin, beta Subunit, Human - blood ; Cohort Studies ; Diseases of mother, fetus and pregnancy ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; Multivariate Analysis ; Placenta Accreta - blood ; Placenta Accreta - epidemiology ; Pregnancy ; Pregnancy. Fetus. Placenta ; Risk Factors</subject><ispartof>Obstetrics and gynecology (New York. 1953), 1999-04, Vol.93 (4), p.545-550</ispartof><rights>1999 The American College of Obstetricians and Gynecologists</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4195-161908b7b5a3fe24ae4d97f54b713efa515f9925423f2a0bdd16b0fd62320ef33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1730355$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10214831$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hung, Tai-Ho</creatorcontrib><creatorcontrib>Shau, Wen-Yi</creatorcontrib><creatorcontrib>Hsieh, Ching-Chang</creatorcontrib><creatorcontrib>Chiu, Tsung-Hong</creatorcontrib><creatorcontrib>Hsu, Jenn-Jeih</creatorcontrib><creatorcontrib>Hsieh, T’Sang-T’Ang</creatorcontrib><title>Risk factors for placenta accreta</title><title>Obstetrics and gynecology (New York. 1953)</title><addtitle>Obstet Gynecol</addtitle><description>Objective: To identify risk factors associated with placenta accreta in a large cohort study.
Methods: Data for this study came from the Taiwan Down Syndrome Screening Group, an ongoing project on feasibility of serum screening in an Asian population. Women who had serum screening for Down syndrome at 14–22 weeks’ gestation using alpha-fetoprotein (AFP) and free β-hCG between January 1994 and June 1997, and delivered in the same institution, were included (
n = 10,672). Those who had multiple gestations (
n = 200), overt diabetes (
n = 11), or fetal malformations (
n = 101) were excluded. If a woman was involved more than once, one randomly selected pregnancy was included in the analysis (
n = 9349). Twenty-eight pregnancies were complicated by placenta accreta, diagnosed by clinical presentation (
n = 26) or histologic confirmation (
n = 2). Multiple logistic regression with adjustment for potentially confounding variables was used to identify independent risk factors for placenta accreta.
Results: Women who had placenta previa (odds ratio [OR] 54.2; 95% confidence interval [CI] 17.8, 165.5) and second-trimester serum levels of AFP and free β-hCG greater than 2.5 multiples of the median (OR 8.3; 95% CI 1.8, 39.3 and OR 3.9; 95% CI 1.5, 9.9, respectively), and were 35 years and older (OR 3.2; 95% CI 1.1, 9.4) were at increased risk of having placenta accreta.
Conclusion: Risk factors for placenta accreta include placenta previa, abnormally elevated second-trimester AFP and free β-hCG levels, and advanced maternal age.</description><subject>Adult</subject><subject>alpha-Fetoproteins - analysis</subject><subject>Biological and medical sciences</subject><subject>Chorionic Gonadotropin, beta Subunit, Human - blood</subject><subject>Cohort Studies</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Multivariate Analysis</subject><subject>Placenta Accreta - blood</subject><subject>Placenta Accreta - epidemiology</subject><subject>Pregnancy</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Risk Factors</subject><issn>0029-7844</issn><issn>1873-233X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkFtr2zAUgMXYWNNsP2Ejg1K6B2_n6GJbT6WEXgaBwS6wNyHLR8SrY6eS09B_PzkO6972JATfp6PzMfYO4RMC5p-_A3CdFaWUF7r8CCBzyMoXbIZlITIuxK-XbPYXOWGnMf4GSKIWr9kJAkdZCpyxD9-aeL_w1g19iAvfh8W2tY66wS6sc4EG-4a98raN9PZ4ztnPm-sfy7ts9fX2y_JqlTmJWmWYo4ayKiplhScuLclaF17JqkBB3ipUXmuuJBeeW6jqGvMKfJ1zwYG8EHN2Pr27Df3DjuJgNk101La2o34XTa4LREj4nKkJdKGPMZA329BsbHgyCGZsYw5tzLi40aU5tDFl8t4fB-yqDdX_WFOMBJwdARudbX2wnWviM1cIEEolTE7Yvm8HCvG-3e0pmDXZdlinaZA-qSBDrTXIdMvG7qN2OWmUIj42yYiuoc5R3QRyg6n75j8L_AElCY2U</recordid><startdate>199904</startdate><enddate>199904</enddate><creator>Hung, Tai-Ho</creator><creator>Shau, Wen-Yi</creator><creator>Hsieh, Ching-Chang</creator><creator>Chiu, Tsung-Hong</creator><creator>Hsu, Jenn-Jeih</creator><creator>Hsieh, T’Sang-T’Ang</creator><general>Elsevier Inc</general><general>The American College of Obstetricians and Gynecologists</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199904</creationdate><title>Risk factors for placenta accreta</title><author>Hung, Tai-Ho ; Shau, Wen-Yi ; Hsieh, Ching-Chang ; Chiu, Tsung-Hong ; Hsu, Jenn-Jeih ; Hsieh, T’Sang-T’Ang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4195-161908b7b5a3fe24ae4d97f54b713efa515f9925423f2a0bdd16b0fd62320ef33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>alpha-Fetoproteins - analysis</topic><topic>Biological and medical sciences</topic><topic>Chorionic Gonadotropin, beta Subunit, Human - blood</topic><topic>Cohort Studies</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Multivariate Analysis</topic><topic>Placenta Accreta - blood</topic><topic>Placenta Accreta - epidemiology</topic><topic>Pregnancy</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hung, Tai-Ho</creatorcontrib><creatorcontrib>Shau, Wen-Yi</creatorcontrib><creatorcontrib>Hsieh, Ching-Chang</creatorcontrib><creatorcontrib>Chiu, Tsung-Hong</creatorcontrib><creatorcontrib>Hsu, Jenn-Jeih</creatorcontrib><creatorcontrib>Hsieh, T’Sang-T’Ang</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hung, Tai-Ho</au><au>Shau, Wen-Yi</au><au>Hsieh, Ching-Chang</au><au>Chiu, Tsung-Hong</au><au>Hsu, Jenn-Jeih</au><au>Hsieh, T’Sang-T’Ang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors for placenta accreta</atitle><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle><addtitle>Obstet Gynecol</addtitle><date>1999-04</date><risdate>1999</risdate><volume>93</volume><issue>4</issue><spage>545</spage><epage>550</epage><pages>545-550</pages><issn>0029-7844</issn><eissn>1873-233X</eissn><coden>OBGNAS</coden><abstract>Objective: To identify risk factors associated with placenta accreta in a large cohort study.
Methods: Data for this study came from the Taiwan Down Syndrome Screening Group, an ongoing project on feasibility of serum screening in an Asian population. Women who had serum screening for Down syndrome at 14–22 weeks’ gestation using alpha-fetoprotein (AFP) and free β-hCG between January 1994 and June 1997, and delivered in the same institution, were included (
n = 10,672). Those who had multiple gestations (
n = 200), overt diabetes (
n = 11), or fetal malformations (
n = 101) were excluded. If a woman was involved more than once, one randomly selected pregnancy was included in the analysis (
n = 9349). Twenty-eight pregnancies were complicated by placenta accreta, diagnosed by clinical presentation (
n = 26) or histologic confirmation (
n = 2). Multiple logistic regression with adjustment for potentially confounding variables was used to identify independent risk factors for placenta accreta.
Results: Women who had placenta previa (odds ratio [OR] 54.2; 95% confidence interval [CI] 17.8, 165.5) and second-trimester serum levels of AFP and free β-hCG greater than 2.5 multiples of the median (OR 8.3; 95% CI 1.8, 39.3 and OR 3.9; 95% CI 1.5, 9.9, respectively), and were 35 years and older (OR 3.2; 95% CI 1.1, 9.4) were at increased risk of having placenta accreta.
Conclusion: Risk factors for placenta accreta include placenta previa, abnormally elevated second-trimester AFP and free β-hCG levels, and advanced maternal age.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>10214831</pmid><doi>10.1016/S0029-7844(98)00460-8</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0029-7844 |
| ispartof | Obstetrics and gynecology (New York. 1953), 1999-04, Vol.93 (4), p.545-550 |
| issn | 0029-7844 1873-233X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69711062 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Adult alpha-Fetoproteins - analysis Biological and medical sciences Chorionic Gonadotropin, beta Subunit, Human - blood Cohort Studies Diseases of mother, fetus and pregnancy Female Gynecology. Andrology. Obstetrics Humans Medical sciences Multivariate Analysis Placenta Accreta - blood Placenta Accreta - epidemiology Pregnancy Pregnancy. Fetus. Placenta Risk Factors |
| title | Risk factors for placenta accreta |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A24%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20for%20placenta%20accreta&rft.jtitle=Obstetrics%20and%20gynecology%20(New%20York.%201953)&rft.au=Hung,%20Tai-Ho&rft.date=1999-04&rft.volume=93&rft.issue=4&rft.spage=545&rft.epage=550&rft.pages=545-550&rft.issn=0029-7844&rft.eissn=1873-233X&rft.coden=OBGNAS&rft_id=info:doi/10.1016/S0029-7844(98)00460-8&rft_dat=%3Cproquest_cross%3E69711062%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69711062&rft_id=info:pmid/10214831&rft_els_id=S0029784498004608&rfr_iscdi=true |